Target intelligence / Profile preview

MAD2L1 divergent transcript (MAD2L1-DT)

Target: MAD2L1-DT
Molecular classification: Long non-coding RNA (lncRNA), Non-coding RNA gene

Overview

MAD2L1 divergent transcript (MAD2L1-DT) is a long non-coding RNA gene that is transcribed from the region adjacent to the MAD2L1 gene. While the functional protein-coding MAD2L1 gene is involved in the spindle assembly checkpoint and cell cycle control, MAD2L1-DT itself does not encode a protein. The precise biological function of MAD2L1-DT remains incompletely characterized, but, as with other lncRNAs, it may be involved in the regulation of gene expression at the transcriptional or post-transcriptional level. Initial research has investigated its expression in cancer contexts, particularly due to the proximity to cancer-related protein-coding genes, but direct biological and disease associations of MAD2L1-DT are still under investigation[2][3].

Other names: MAD2L1-DT (common gene symbol)MAD2L1 divergent transcript

Biological functions

Regulation of gene expression (general function of lncRNAs)Possible roles in cell cycle regulation (by proximity/functional association with MAD2L1)

Disease associations

Cancer (lncRNAs located near MAD2L1, such as MAD2L1-DT, have been investigated for association with cancer phenotypes)Other disease roles: insufficient direct evidence for other specific diseases

Biomarkers

Possible biomarker in cancer research (some lncRNAs near MAD2L1 demonstrate diagnostic/prognostic potential in cancer[2]; direct evidence for MAD2L1-DT specifically is limited)

Beyond the preview

Go deeper on MAD2L1 divergent transcript (MAD2L1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAD2L1 divergent transcript (MAD2L1-DT).

Explore the full profile